Iterum Therapeutics Plc

News

Gabelli & Co gives a Hold recommendation for Iterum Therapeutics Plc (ITRM)

Anna Perez

Iterum Therapeutics Plc’s recently made public that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov ...

Stock Earnings

ITRM stock rated a Hold by Gabelli & Co

Roman Campbell

Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...

Stock Earnings

A Guide To The Risks Of Investing In Iterum Therapeutics Plc (ITRM)

Jaxson Clark

Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...

Stock Earnings

Understanding the Risks of Investing in Iterum Therapeutics Plc (ITRM)

Jaxson Clark

Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.